Warsaw, Poland

Marcin Cybulski



Average Co-Inventor Count = 7.0

ph-index = 2

Forward Citations = 8(Granted Patents)


Location History:

  • Houston, TX (US) (2019)
  • Warsaw, PL (2015 - 2024)

Company Filing History:


Years Active: 2015-2024

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Marcin Cybulski: Innovator in Biochemical Research

Introduction

Marcin Cybulski is a prominent inventor based in Warsaw, Poland. He has made significant contributions to the field of biochemical research, particularly in the development of compounds with potential therapeutic applications. With a total of 6 patents to his name, Cybulski's work is recognized for its innovative approach to addressing complex health issues.

Latest Patents

Among his latest patents, Cybulski has developed methods related to esters of 2-deoxy-monosaccharides that exhibit anti-proliferative activity. These compounds are designed to inhibit glycolysis, offering potential treatments for cancer and other diseases. Additionally, he has improved the process of preparing vitamin K2 derivatives, represented by a specific formula where n is an integer from 3 to 13.

Career Highlights

Cybulski has worked with notable institutions, including the University of Texas System and the Łukasiewicz Research Network - Industrial Chemistry Research Institute. His career reflects a commitment to advancing scientific knowledge and developing practical applications for his research.

Collaborations

Throughout his career, Marcin Cybulski has collaborated with esteemed colleagues such as Waldemar Priebe and Izabela Fokt. These partnerships have further enriched his research and contributed to the success of his innovative projects.

Conclusion

Marcin Cybulski stands out as a key figure in biochemical innovation, with a focus on developing compounds that could lead to significant advancements in medical treatments. His contributions continue to impact the field positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…